Navigation Links
Isis Pharmaceuticals To Present At The 24th Annual Piper Jaffray Healthcare Conference
Date:11/20/2012

CARLSBAD, Calif., Nov. 20, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27, 2012 at 1:00 p.m. ET in New York, NY.

A live audio webcast of the presentation and panel will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

FORWARD-LOOKING STATEMENTS
This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discoverin
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
2. Global Pharmaceuticals & Medicine Manufacturing
3. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
4. Validus Pharmaceuticals Now Exclusively Marketing Six Established U.S. Product Lines Purchased From Leading Healthcare Company
5. Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
6. Building on a Legacy: Vinita Gupta, CEO of Lupin Pharmaceuticals, Inc., Named Ernst & Young U.S. 2012 Family Business Award of Excellence winner
7. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
8. Auspex Pharmaceuticals Receives U.S. Patent on Novel JAK Inhibitor SD-900
9. Access Pharmaceuticals To Host Third Quarter Investor Call on Wednesday, November 28th
10. Ground Zero Pharmaceuticals, Inc. (GZP) Announces Enhanced Biosimilars and Personalized Medicine Initiatives for its Clients
11. Cardioxyl Pharmaceuticals Raises $28 Million In Series B Financing Led By OrbiMed Advisors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015 For the pharmaceutical industry, marketplace success ... payers. Likewise, the importance of the managed markets function - ... to grow as payer formularies and provider networks play an ... At the same time, managed markets leaders must continually identify ...
(Date:1/23/2015)... Markets ( http://www.researchandmarkets.com/research/vzhr6h/video ) has announced the addition ... Share, Growth, Trends and Forecast 2014 - 2020" report ... topic of fascination since the era of the cold war ... Soviet Russia. Earlier even a small glimpse of human form ...
(Date:1/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5dh22x/urinary_catheters ) has ... (Indwelling or Foley Catheters, Intermittent Catheters and Male External ... Growth, Trends and Forecast 2014 - 2020" report ... the global market for urinary catheters is experiencing a ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Urinary Catheters Market (Indwelling or Foley Catheters, Intermittent Catheters and Male External or Condom Catheters) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3
... Fla., Nov. 13 Royal Philips Electronics (NYSE: PHG, ... the Moffitt Cancer Center in Tampa, Fla. became the ... therapy planned with Philips, Pinnacle3 SmartArc technology. SmartArc ... treatment planning, an advanced form of intensity-modulated radiation therapy ...
... 13 CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), ... segment of the IVD testing market, was featured in ... , The article by Amanda Petersen, titled "CardioGenics aims ... CardioGenics CEO Yahia Gawad, MD regarding the company,s point-of-care ...
Cached Medicine Technology:Philips' SmartArc Solution Helps Moffitt Cancer Center Reduce Radiation Treatment Time 2Philips' SmartArc Solution Helps Moffitt Cancer Center Reduce Radiation Treatment Time 3CardioGenics Holdings Inc. Featured in Medical Device Daily 2CardioGenics Holdings Inc. Featured in Medical Device Daily 3
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... (PRWEB) January 23, 2015 VogueQueen is a ... affordable prices and many designers are thrilled to have it ... business announces its new collection of prom dresses for the ... to drive the strategic vision and he focuses on continuing ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... 22, 2015 Joan Lunden, award-winning American ... at the upcoming 32nd Annual Miami Breast Cancer ... Education Resource®, LLC (PER®) , shares that “a fast-growing, ... undetected if she had not followed up her clean ...
Breaking Medicine News(10 mins):Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... -- When patients choose to leave the hospital before ... risk of inadequately treated medical conditions and the need ... 2009 issue of Mayo Clinic Proceedings . Additionally, ... as predictors and potential interventions to help manage and ...
... 2009Chemicals present in cranberriesand not the acidity of cranberry ... the cells that line the urinary tract, as documented ... Food , a peer-reviewed journal published by Mary Ann ... free online at www.liebertpub.com/jmf , Urinary tract ...
... leadership prepares company for continued growthATLANTA, March ... today announced it has grown to 275 ... these announcements, Reveille positions itself for continued ... end-user experience and application performance management.Reveille,s solution, ...
... 9 The Department of Health today launched ... PA EPHTN, which will track key environmental hazards, ... safe from potential environmental health hazards is a ... tracking network will help us take a major ...
... Ltd., a medical device company publicly traded on the Tel-Aviv ... in the peer-reviewed Journal of Human Hypertension . The ... the journal,s website. The study will also be published in ... It demonstrates use of RESPeRATEthe only medical device cleared by ...
... Systems (SIS) unveils SIS Trax, a tissue management solution ... means for hospitals to standardize their processes for acquiring, ... tracking solution to be fully integrated with a perioperative ... that enables hospitals to improve patient safety, optimize revenue, ...
Cached Medicine News:Health News:Patients being discharged against medical advice 2Health News:New research reveals how cranberry products prevent urinary tract infections 2Health News:Reveille Software Reaches Customer Milestone and Expands Executive Team 2Health News:Reveille Software Reaches Customer Milestone and Expands Executive Team 3Health News:Pennsylvania Department of Health Launches New Environmental Health Tracking Tool 2Health News:New published study demonstrates over-the-counter device lowers blood pressure in diabetic patients 2Health News:SIS Trax Unveiled as First Fully Integrated Tissue Management Solution 2
Beuse Zygomatic Arch Awl with slightly curved tip....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
Steroid-eluting, single-pass lead. CapSure VDD2 optimizes VDD therapy and offers easier handling, proven performance, and choice....
CapSureSP Novus 5594 is a J-shaped, endocardial, tined pacing lead. provide the stable, low pacing thresholds and large sensing potentials already proven with CapSure SP steroid-eluting leads but wi...
Medicine Products: